Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusionCancer Immunology, Immunotherapy, 2022-02, Vol.71 (2), p.365-372 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0340-7004 ;EISSN: 1432-0851 ;DOI: 10.1007/s00262-021-02994-5 ;PMID: 34170380Full text available |
|
2 |
Material Type: Article
|
High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patientsProceedings of the National Academy of Sciences - PNAS, 2017-03, Vol.114 (10), p.2544-2549 [Peer Reviewed Journal]Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Mar 7, 2017 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1612229114 ;PMID: 28223509Full text available |
|
3 |
Material Type: Article
|
Pleural DiseaseThe New England journal of medicine, 2018-02, Vol.378 (8), p.740-751 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1403503 ;PMID: 29466146Full text available |
|
4 |
Material Type: Article
|
Myelomatous pleural effusion in multiple myeloma- A rare presentationJournal of cancer research and therapeutics, 2024-01, Vol.20 (1), p.476-478 [Peer Reviewed Journal]Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics. ;COPYRIGHT 2024 Medknow Publications and Media Pvt. Ltd. ;2024. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0973-1482 ;EISSN: 1998-4138 ;DOI: 10.4103/jcrt.jcrt_1772_22 ;PMID: 38554369Full text available |
|
5 |
Material Type: Article
|
High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusionMedicine (Baltimore), 2019-09, Vol.98 (38), p.e17253-e17253 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000017253 ;PMID: 31567996Full text available |
|
6 |
Material Type: Article
|
Cell-free DNA methylation analysis as a marker of malignancy in pleural fluidScientific reports, 2024-02, Vol.14 (1), p.2939-2939, Article 2939 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-53132-x ;PMID: 38316884Full text available |
|
7 |
Material Type: Article
|
Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical ParametersLung, 2017-10, Vol.195 (5), p.653-660 [Peer Reviewed Journal]Springer Science+Business Media, LLC 2017 ;COPYRIGHT 2017 Springer ;Lung is a copyright of Springer, 2017. ;ISSN: 0341-2040 ;EISSN: 1432-1750 ;DOI: 10.1007/s00408-017-0032-3 ;PMID: 28656381Full text available |
|
8 |
Material Type: Article
|
Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysisMedicine (Baltimore), 2019-04, Vol.98 (14), p.e14979-e14979 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000014979 ;PMID: 30946324Full text available |
|
9 |
Material Type: Article
|
Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant EffusionThe New England journal of medicine, 2018-04, Vol.378 (14), p.1313-1322 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1716883 ;PMID: 29617585Full text available |
|
10 |
Material Type: Article
|
P209 Establishing a pleural clinic and local anaesthetic thoracoscopy service in a small secondary referral hospital: a review of over 1000 pleural clinic attendances in Singleton HospitalThorax, 2021-02, Vol.76 (Suppl 1), p.A203-A203 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thorax-2020-BTSabstracts.354Full text available |
|
11 |
Material Type: Article
|
Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusionNature nanotechnology, 2022-02, Vol.17 (2), p.206-216 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;ISSN: 1748-3387 ;EISSN: 1748-3395 ;DOI: 10.1038/s41565-021-01032-w ;PMID: 34916656Full text available |
|
12 |
Material Type: Article
|
Biomarkers in the diagnosis of pleural diseases: a 2018 updateTherapeutic Advances in Respiratory Disease, 2018-01, Vol.12, p.1753466618808660-1753466618808660 [Peer Reviewed Journal]The Author(s), 2018 ;The Author(s), 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://www.creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), 2018 2018 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1753-4666 ;ISSN: 1753-4658 ;EISSN: 1753-4666 ;DOI: 10.1177/1753466618808660 ;PMID: 30354850Full text available |
|
13 |
Material Type: Article
|
Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell BlocksAnticancer research, 2023-02, Vol.43 (2), p.669 [Peer Reviewed Journal]ISSN: 1791-7530 ;ISSN: 0250-7005 ;EISSN: 1791-7530 ;DOI: 10.21873/anticanres.16204Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Features which discriminate between tuberculosis and haematologic malignancy as the cause of pleural effusions with high adenosine deaminaseRespiratory research, 2024-01, Vol.25 (1), p.17-17, Article 17 [Peer Reviewed Journal]2023. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-023-02645-6 ;PMID: 38178065Full text available |
|
15 |
Material Type: Article
|
S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusionIndian journal of cancer, 2021-04, Vol.58 (2), p.241-247 [Peer Reviewed Journal]COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd. ;2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0019-509X ;EISSN: 1998-4774 ;DOI: 10.4103/ijc.IJC_149_19Full text available |
|
16 |
Material Type: Article
|
Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusionThe Korean journal of internal medicine, 2024-03, Vol.39 (2), p.318-326 [Peer Reviewed Journal]Copyright © 2024 The Korean Association of Internal Medicine 2024 ;ISSN: 1226-3303 ;EISSN: 2005-6648 ;DOI: 10.3904/kjim.2023.309 ;PMID: 38351680Full text available |
|
17 |
Material Type: Article
|
Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort studyBMC cancer, 2020-08, Vol.20 (1), p.825-8, Article 825 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07327-w ;PMID: 32867726Full text available |
|
18 |
Material Type: Article
|
CT imaging features of 4121 patients with COVID‐19: A meta‐analysisJournal of Medical Virology, 2020-07 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25910Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Interventions for the management of malignant pleural effusions: a network meta‐analysisCochrane database of systematic reviews, 2020-04, Vol.2020 (4), p.CD010529-CD010529 [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD010529.pub3 ;PMID: 32315458Full text available |
|
20 |
Material Type: Article
|
Incidence of complications from indwelling pleural catheter for pleural effusion: A meta‐analysisClinical and translational science, 2023-01, Vol.16 (1), p.104-117 [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;2022 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1752-8054 ;EISSN: 1752-8062 ;DOI: 10.1111/cts.13430 ;PMID: 36253892Full text available |